Halozyme Therapeutics
Price & Volume
Stats
See more52W Range | $47.50-$82.22 |
Market Cap | $7.9B |
Shares Short | 14M |
Financials
See moreRevenue (12 Mos) | $1.3B |
Revenue Growth (YoY) | 51.6% |
Gross Profit (12 Mos) | $1B |
Diluted EPS | $2.57 |
News
See moreYahoo Finance • 9 days ago
Halozyme Announces Global Collaboration and License Agreement with Vertex Pharmaceuticals for Hypercon™ Technology
Yahoo Finance • 17 days ago
Halozyme Therapeutics (HALO) Appoints Interim CFO Amid Growth Plans
Yahoo Finance • last month
Sector Update: Health Care Stocks Retreat Late Afternoon
Yahoo Finance • last month
U.S. FDA Approves TECVAYLI® in Combination with DARZALEX FASPRO® for Relapsed/Refractory Multiple Myeloma
About
CEO | Dr. Helen I. Torley M.B. Ch. B., M.R.C.P. |
Address | 12390 El Camino Real, San Diego, CA, United States, 92130 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 423 |
